Outcomes of Surgical Treatment of Malar Mounds and Festoons.
Correction of festoons
Festoons
Malar bags
Malar edema
Malar mounds
Treatment of festoons
Journal
Aesthetic plastic surgery
ISSN: 1432-5241
Titre abrégé: Aesthetic Plast Surg
Pays: United States
ID NLM: 7701756
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
21
12
2022
accepted:
23
04
2023
medline:
23
10
2023
pubmed:
31
5
2023
entrez:
31
5
2023
Statut:
ppublish
Résumé
Malar mounds (congenital) and festoons (acquired) are persistent puffiness in the prezygomatic space between the orbicularis retaining ligament (ORL) and zygomatico-cutaneous ligament (ZCL). Non-surgical treatments often yield unsatisfactory results. This paper aims to demonstrate a surgical approach for the treatment of malar bags by outlining the author's surgical technique of treating malar mounds and festoons and reviewing outcomes in 89 cases. Correction of malar mounds and festoons was achieved with subciliary skin-muscle flap, release of the ORL and ZCL, midface lift, canthopexy, and muscle suspension. We performed a retrospective study of 89 patients, all of whom had surgical correction of malar mounds or festoons in the past 10 years and a follow-up period of at least 6 months. This study was conducted over the course of the past year and involved reviewing patient charts in the office. Specifically, patient data spanning 2012 to 2022 were analyzed. The predictor variable in this study is the specific class of malar bags the patient has, as determined by the underlying pathophysiology. Outcome variables include the presence or absence of prolonged lid or malar edema, necessary re-excision of excess orbicularis oculi of the subciliary area, lid malposition, permanent visual changes, the need for additional non-operative treatment, and recurrence requiring reoperation. The majority of patients presented with acquired festoons (81/89) with prior attempts of correction (49/89). The mean follow-up is 11.2 months. Persistent malar edema (> 6 weeks) was documented in 14 patients and mainly resolved with Medrol Dosepak (methylprednisolone) and hydrochlorothiazide. A two-proportion Z-test was conducted, comparing the proportion of patients with poor protoplasm who experienced postoperative malar edema to the proportion of those with excellent protoplasm who experienced postoperative malar edema. A p-value of 3.414e Malar mounds and festoons present a unique challenge to plastic surgeons. They are persistent in nature and require close-interval, long-term follow-up as additional injections and reoperations are warranted. Our approach to malar mound and festoon correction is safe and effective and provides long-lasting results. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Sections du résumé
BACKGROUND
Malar mounds (congenital) and festoons (acquired) are persistent puffiness in the prezygomatic space between the orbicularis retaining ligament (ORL) and zygomatico-cutaneous ligament (ZCL). Non-surgical treatments often yield unsatisfactory results. This paper aims to demonstrate a surgical approach for the treatment of malar bags by outlining the author's surgical technique of treating malar mounds and festoons and reviewing outcomes in 89 cases.
METHODS
Correction of malar mounds and festoons was achieved with subciliary skin-muscle flap, release of the ORL and ZCL, midface lift, canthopexy, and muscle suspension. We performed a retrospective study of 89 patients, all of whom had surgical correction of malar mounds or festoons in the past 10 years and a follow-up period of at least 6 months. This study was conducted over the course of the past year and involved reviewing patient charts in the office. Specifically, patient data spanning 2012 to 2022 were analyzed. The predictor variable in this study is the specific class of malar bags the patient has, as determined by the underlying pathophysiology. Outcome variables include the presence or absence of prolonged lid or malar edema, necessary re-excision of excess orbicularis oculi of the subciliary area, lid malposition, permanent visual changes, the need for additional non-operative treatment, and recurrence requiring reoperation.
RESULTS
The majority of patients presented with acquired festoons (81/89) with prior attempts of correction (49/89). The mean follow-up is 11.2 months. Persistent malar edema (> 6 weeks) was documented in 14 patients and mainly resolved with Medrol Dosepak (methylprednisolone) and hydrochlorothiazide. A two-proportion Z-test was conducted, comparing the proportion of patients with poor protoplasm who experienced postoperative malar edema to the proportion of those with excellent protoplasm who experienced postoperative malar edema. A p-value of 3.414e
CONCLUSION
Malar mounds and festoons present a unique challenge to plastic surgeons. They are persistent in nature and require close-interval, long-term follow-up as additional injections and reoperations are warranted. Our approach to malar mound and festoon correction is safe and effective and provides long-lasting results.
LEVEL OF EVIDENCE IV
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Identifiants
pubmed: 37256298
doi: 10.1007/s00266-023-03381-4
pii: 10.1007/s00266-023-03381-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1418-1429Informations de copyright
© 2023. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.
Références
Furnas DW (1978) Festoons of orbicularis muscle as a cause of baggy eyelids. Plast Reconstr Surg 61(4):540–546. https://doi.org/10.1097/00006534-197804000-00007
doi: 10.1097/00006534-197804000-00007
pubmed: 635044
Mendelson BC, Muzaffar AR, Adams WP Jr (2002) Surgical anatomy of the midcheek and malar mounds. Plast Reconstr Surg 110(3):885–911. https://doi.org/10.1097/00006534-200209010-00026
doi: 10.1097/00006534-200209010-00026
pubmed: 12172155
Mendelson BC, Jacobson SR (2008) Surgical anatomy of the midcheek: facial layers, spaces, and the midcheek segments. Clin Plast Surg 35(3):395–393. https://doi.org/10.1016/j.cps.2008.02.003
doi: 10.1016/j.cps.2008.02.003
pubmed: 18558234
Muzaffar AR, Mendelson BC, Adams WP Jr (2002) Surgical anatomy of the ligamentous attachments of the lower lid and lateral canthus. Plast Reconstr Surg 110(3):873–911. https://doi.org/10.1097/00006534-200209010-00025
doi: 10.1097/00006534-200209010-00025
pubmed: 12172154
Newberry CI, Mccrary H, Thomas JR, Cerrati EW (2020) Updated management of malar edema, mounds, and festoons: a systematic review. Aesthet Surg J 40(3):246–258. https://doi.org/10.1093/asj/sjz137
doi: 10.1093/asj/sjz137
pubmed: 31051517
Ausen K, Fossmark R, Spigset O, Pleym H (2022) Safety and efficacy of local tranexamic acid for the prevention of surgical bleeding in soft-tissue surgery: a review of the literature and recommendations for plastic surgery. Plast Reconstr Surg 149(3):774–787. https://doi.org/10.1097/PRS.0000000000008884
doi: 10.1097/PRS.0000000000008884
pubmed: 35196701
pmcid: 8860217
Laikhter E, Comer CD, Shiah E, Manstein SM, Bain PA, Lin SJ (2022) A systematic review and meta-analysis evaluating the impact of tranexamic acid administration in aesthetic plastic surgery. Aesthet Surg J 42(5):548–558. https://doi.org/10.1093/asj/sjab333
doi: 10.1093/asj/sjab333
pubmed: 34486647
Locketz GD, Lozada KN, Bloom JD (2020) Tranexamic acid in aesthetic facial plastic surgery: a systematic review of evidence, applications, and outcomes. Aesthet Surg J Open Forum 2(3):ojaa029. https://doi.org/10.1093/asjof/ojaa029
doi: 10.1093/asjof/ojaa029
pubmed: 33791652
pmcid: 7671246
Murphy GR, Glass GE, Jain A (2016) The efficacy and safety of tranexamic acid in cranio-maxillofacial and plastic surgery. J Craniofac Surg 27(2):374–379. https://doi.org/10.1097/SCS.0000000000002250
doi: 10.1097/SCS.0000000000002250
pubmed: 26967076
Wang S, Yang J, Lin L (2023) Local application of tranexamic acid in plastic surgery patients: a systematic review and meta-analysis of randomized controlled trials. Aesthetic Plast Surg. https://doi.org/10.1007/s00266-023-03281-7
doi: 10.1007/s00266-023-03281-7
pubmed: 37488312
pmcid: 10196311
Tran BNN, Luthringer M, Reed L, Asaadi M (2022) Addition of “septal window” to lower blepharoplasty for the management of fat of the lower eyelids. Ann Plast Surg 88(3 Suppl 3):S214–S218. https://doi.org/10.1097/SAP.0000000000003129
doi: 10.1097/SAP.0000000000003129
pubmed: 35276712
Chon BH, Hwang CJ, Perry JD (2020) Long-term patient experience with tetracycline injections for festoons. Plast Reconstr Surg 146(6):737e–743e. https://doi.org/10.1097/PRS.0000000000007334
doi: 10.1097/PRS.0000000000007334
pubmed: 33234952
Chon BH, Hwang CJ, Perry JD (2021) Treatment options for lower eyelid festoons. Facial Plast Surg Clin North Am 29(2):301–309. https://doi.org/10.1016/j.fsc.2021.02.005
doi: 10.1016/j.fsc.2021.02.005
pubmed: 33906762
Endara M, Oh C, Davison SP, Baker SB (2015) The management of festoons. Clin Plast Surg 42(1):87–94. https://doi.org/10.1016/j.cps.2014.08.006
doi: 10.1016/j.cps.2014.08.006
pubmed: 25440745
Jeon H, Geronemus RG (2018) Successful noninvasive treatment of festoons. Plast Reconstr Surg 141(6):977e–978e. https://doi.org/10.1097/PRS.0000000000004400
doi: 10.1097/PRS.0000000000004400
pubmed: 29794724
Žgaljardić Z, Žgaljardić I, Jurić F (2021) Treatment of malar mound and festoon with fractional microneedle bipolar radiofrequency combined with 15% TCA peel. J Cosmet Dermatol 20(6):1810–1812. https://doi.org/10.1111/jocd.13740
doi: 10.1111/jocd.13740
pubmed: 32985067
Kpodzo DS, Nahai F, McCord CD (2014) Malar mounds and festoons: review of current management. Aesthet Surg J 34(2):235–248. https://doi.org/10.1177/1090820X13517897
doi: 10.1177/1090820X13517897
pubmed: 24431347
Krakauer M, Aakalu VK, Putterman AM (2012) Treatment of malar festoon using modified subperiosteal midface lift. Ophthalmic Plast Reconstr Surg 28(6):459–462. https://doi.org/10.1097/IOP.0b013e3182696902
doi: 10.1097/IOP.0b013e3182696902
pubmed: 23138206
Pessa JE, Garza JR (1997) The malar septum: the anatomic basis of malar mounds and malar edema. Aesthet Surg J 17(1):11–17. https://doi.org/10.1016/s1090-820x(97)70001-3
doi: 10.1016/s1090-820x(97)70001-3
pubmed: 19327681